There are no data available on adverse reactions from Baxalta-sponsored clinical trials conducted with BUMINATE 25%.
The following adverse reactions have been reported in the post-marketing experience.
Immune System Disorders : Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions
Nervous System Disorders : Headache, dysgeusia
Cardiac Disorders : Myocardial infarction, atrial fibrillation, tachycardia
Vascular Disorders : Hypotension, flushing
Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, dyspnea
Gastrointestinal Disorders : Vomiting, nausea
Skin and Subcutaneous Tissue Disorders : Urticaria, rash, pruritus
General Disorders and Administration Site Conditions : Pyrexia, chills
SRC: NLM .
This material is solely for educational purposes; it isn’t intended to provide medical advice or diagnosis.
© Copyright 2022 MDtodate.com – All Rights Reserved.